TXMD - TherapeuticsMD Inc

https://www.therapeuticsmd.com

Recent News

TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying - TherapeuticsMD ( NASDAQ:TXMD )

The Dow Jones index closed higher by more than 450 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading ...

Bullish

TherapeuticsMD ( NASDAQ:TXMD ) Receives New Coverage from Analysts at StockNews.com

Stocknews.com • 1 year, 2 months ago • score: 0.55

Equities research analysts at StockNews.com assumed coverage on shares of TherapeuticsMD ( NASDAQ:TXMD - Get Free Report ) in a report issued on Friday. The firm set a "hold" rating on the stock. Shares of TXMD stock opened at $1.78 on Friday. TherapeuticsMD has a 12-month low of $1.43 and a ...

Bullish

StockNews.com Begins Coverage on TherapeuticsMD ( NASDAQ:TXMD )

Stocknews.com • 1 year, 2 months ago • score: 0.43

Stock analysts at StockNews.com initiated coverage on shares of TherapeuticsMD ( NASDAQ:TXMD - Get Free Report ) in a research report issued on Saturday. The firm set a "hold" rating on the stock. NASDAQ TXMD opened at $1.51 on Friday.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

TherapeuticsMD, Inc. is a women's healthcare company in the United States. The company is headquartered in Boca Raton, Florida.

52W High

$1.84

52W Low

$0.70

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.51

Valuation

Attractive

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

2.29

EV/EBITDA (<8 favorable)

14.81

EV/Revenue (<3 favorable)

5.09

P/S (TTM) (<3 favorable)

4.89

P/B (<3 favorable)

0.46

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

1.55%

Institutions (25–75% balanced)

28.14%

Shares Outstanding

11,574,400

Float

9,560,800

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

2,559,000

Gross Profit (TTM)

2,559,000

EPS (TTM)

-0.05

Profit Margin (>10% good)

-0.18%

Operating Margin (TTM) (higher better)

-0.34%

ROE (TTM) (>15% strong)

-0.02%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

3.07

Momentum

Value

N/A

Trend

—

Signal Cross

No cross

As of

—